Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes
NJ Hogrebe, M Ishahak, JR Millman - Cell Stem Cell, 2023 - cell.com
The generation of islet-like endocrine clusters from human pluripotent stem cells (hPSCs)
has the potential to provide an unlimited source of insulin-producing β cells for the treatment …
has the potential to provide an unlimited source of insulin-producing β cells for the treatment …
Mechanical regulation of chromatin and transcription
S Dupont, SA Wickström - Nature Reviews Genetics, 2022 - nature.com
Cells and tissues generate and are exposed to various mechanical forces that act across a
range of scales, from tissues to cells to organelles. Forces provide crucial signals to inform …
range of scales, from tissues to cells to organelles. Forces provide crucial signals to inform …
100 years of insulin: celebrating the past, present and future of diabetes therapy
The year 2021 marks the centennial of Banting and Best's landmark description of the
discovery of insulin. This discovery and insulin's rapid clinical deployment effectively …
discovery of insulin. This discovery and insulin's rapid clinical deployment effectively …
[HTML][HTML] Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques
X Hu, K White, AG Olroyd, R DeJesus… - Nature …, 2024 - nature.com
Genetic engineering of allogeneic cell therapeutics that fully prevents rejection by a
recipient's immune system would abolish the requirement for immunosuppressive drugs or …
recipient's immune system would abolish the requirement for immunosuppressive drugs or …
Generation of insulin-producing pancreatic β cells from multiple human stem cell lines
NJ Hogrebe, KG Maxwell, P Augsornworawat… - Nature protocols, 2021 - nature.com
We detail a six-stage planar differentiation methodology for generating human pluripotent
stem cell–derived pancreatic β cells (SC-β cells) that secrete high amounts of insulin in …
stem cell–derived pancreatic β cells (SC-β cells) that secrete high amounts of insulin in …
Human pluripotent stem-cell-derived islets ameliorate diabetes in non-human primates
Y Du, Z Liang, S Wang, D Sun, X Wang, SY Liew… - Nature medicine, 2022 - nature.com
Human pluripotent stem-cell-derived islets (hPSC-islets) are a promising cell resource for
diabetes treatment,. However, this therapeutic strategy has not been systematically …
diabetes treatment,. However, this therapeutic strategy has not been systematically …
Single-nucleus multi-omics of human stem cell-derived islets identifies deficiencies in lineage specification
P Augsornworawat, NJ Hogrebe, M Ishahak… - Nature Cell …, 2023 - nature.com
Insulin-producing β cells created from human pluripotent stem cells have potential as a
therapy for insulin-dependent diabetes, but human pluripotent stem cell-derived islets (SC …
therapy for insulin-dependent diabetes, but human pluripotent stem cell-derived islets (SC …
Biomaterials for in situ cell therapy
Cell therapy has revolutionized the treatment of various diseases, such as cancers, genetic
disorders, and autoimmune diseases. Currently, most cell therapy products rely on ex vivo …
disorders, and autoimmune diseases. Currently, most cell therapy products rely on ex vivo …
[HTML][HTML] Deciphering early human pancreas development at the single-cell level
Understanding pancreas development can provide clues for better treatments of pancreatic
diseases. However, the molecular heterogeneity and developmental trajectory of the early …
diseases. However, the molecular heterogeneity and developmental trajectory of the early …
Engineering islets from stem cells for advanced therapies of diabetes
Diabetes mellitus is a metabolic disorder that affects more than 460 million people
worldwide. Type 1 diabetes (T1D) is caused by autoimmune destruction of β-cells, whereas …
worldwide. Type 1 diabetes (T1D) is caused by autoimmune destruction of β-cells, whereas …